ICSC (232447)

  https://cordis.europa.eu/project/id/232447

  FP7 (2007-2013)

  Integrated Chemical synthesis and Screening in patient Cells

  Research for SMEs (SME-1)

  drug discovery  ·  philosophy

  2009-03-01 Start Date (YY-MM-DD)

  2011-08-31 End Date (YY-MM-DD)

  € 1,388,534 Total Cost


  Description

The ICSC project is a “Research for SMEs” focused research project that is to develop an integrated high throughput chemical synthesis and cell-based screening platform for the development of efficacious novel drug candidates without the need for chemical nor cell biological infrastructure. The technology will put early drug discovery in the hands of institutions that have a comprehensive knowledge of disease mechanisms and management of patients. The technological core of the ICSC project is a newly developed high-throughput drug discovery technology ChemoCellomics®, which integrates chemical synthesis and high throughput cell-based screening in a polymer-based format. The ChemoCellomics® technology will in the ICSC project be converted to a bench-top technology where optically encoded micro carriers will hold chemical library member and patient cells. The structural identity of the chemical library member is optically encoded in each carrier. It is expected that the ICSC technology will have a major impact on multiple areas within life sciences in particular drug discovery. Early drug screening and development of drug candidates including synthesis of chemical libraries and high throughput cell-based screening have previously been reserved pharmaceutical- and major biotechnology companies with comprehensive chemistry- and cell biological infrastructure. The philosophy behind the development of the ICSC technology is to provide institutions (hospitals, academia and small biotechnology companies) possessing detailed knowledge about disease mechanisms and patient treatment, with a capability to exploit this knowledge in early drug discovery.


  Complicit Organisations

1 Israeli organisation participates in ICSC.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
Denmark REGION HOVEDSTADEN (999654744) DK30113721 participant PUB € 0 € 3,200 € 0
Israel PROTEIN LABORATORIES REHOVOT LTD (997992552) nan participant PRC € 0 € 206,100 € 0
Spain MICROLIQUID SL (997988478) ESB20975124 participant PRC € 0 € 235,500 € 0
Denmark 2CUREX A/S (998138149) DK29418888 coordinator PRC € 0 € 604,000 € 0
United Kingdom UNIVERSITY OF SOUTHAMPTON (999975329) GB568630414 participant HES € 0 € 4,000 € 0
Denmark DANMARKS TEKNISKE UNIVERSITET (999990655) DK30060946 participant HES € 0 € 3,200 € 0